Protox completes botulinum toxin plant in Hwaseong, South Korea

Protox, a DSK subsidiary, held a completion ceremony for its botulinum toxin bio-production plant in Hwaseong, Gyeonggi Province. The plant cost about KRW 32 billion and has a total floor area of 6,227 m² over four floors with GMP facilities. It can produce 2.7 million vials of botulinum toxin annually.

“프로톡스는 이번 공장 준공을 계기로 연간 270만 바이알 규모의 보툴리눔 톡신 제제를 생산할 수 있으며”m.dailypharm.com

• 1 source
• m.dailypharm.com[데일리팜]프로톡스, 보툴리눔 톡신 공장 준공…320억원 투입Apr 26, 2019

Summarized from public sources; check the original articles before acting on it.